Skip to main content
Takeda to sell Osaka headquarters ahead of Shire purchase
7/6/2018

Takeda Pharmaceutical intends to sell its Osaka, Japan, headquarters ahead of the planned purchase of Shire for $62 billion. The sale of the headquarters property could net Takeda more than $540 million.

Full Story: